Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2019-01-30 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于股东减持公司股份的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder's reduction in company shares, detailing the number of shares sold, dates, prices, and compliance with relevant securities regulations. It references specific regulatory rules about shareholder and insider share reductions. The content focuses on the shareholder's shareholding changes and compliance statements, without any financial statements or earnings data. This matches the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2019-01-30 Chinese
关于子公司收到药品GMP证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about its subsidiary receiving a GMP certificate issued by a regulatory authority. It does not contain financial statements, management discussion, or detailed financial data. The length is only 580 characters, and it is an announcement of a certification related to product quality compliance. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit into any other specific category such as financial reports or management information.
2019-01-30 Chinese
关于子公司收到药品GMP证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (605 characters) about a subsidiary receiving a GMP certificate from a regulatory authority (Hubei Provincial Drug Administration). It is a formal disclosure of a regulatory compliance update rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. The document is an official announcement of a regulatory certificate issuance, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-01-29 Chinese
2018年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2018 annual performance forecast (业绩预告) for 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It covers the expected net profit/loss for the full fiscal year 2018 (January 1 to December 31, 2018). The document explicitly states it is an earnings forecast and not audited, with detailed explanations of goodwill impairment and business performance. It is not a full annual report (10-K) but a preliminary earnings release or forecast. The document length is short (1715 characters), and it contains specific financial performance expectations for the year, which aligns with an Earnings Release (ER) rather than a full Annual Report or Interim Report. Therefore, the best classification is Earnings Release (ER). FY 2018
2019-01-25 Chinese
关于高管股份减持计划期间届满暨实施情况的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion and implementation of a share reduction plan by a senior executive (黄涛) of the company 福安药业. It details the number of shares reduced, the method of reduction, dates, and compliance with relevant regulations. The content focuses on insider share transactions by a company director or senior management, specifically the reduction of shares held by an executive. There is no financial report, earnings data, or management discussion of financial results. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short (1804 characters), and it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is DIRS (Director's Dealing).
2019-01-23 Chinese
关于股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by certain shareholders of the company. It details the number of shares released from pledge, the shareholders involved, and the proportion of shares pledged and released. There is no financial report, earnings data, management discussion, or regulatory certification. The content is about a change in share pledge status, which relates to capital structure but is specifically about share pledge release, not new financing or capital raising. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about share pledge status, which does not fit into more specific categories like Capital/Financing Update (CAP) or Transaction in Own Shares (POS). The document is short and is an announcement, not a report or detailed filing.
2019-01-14 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.